Why Outsource Foreign Matter Analysis?

It is important to have a good understanding of your manufacturing process in order to implement effective controls to prevent future contamination. However, such analyses require the right instrumentation, specialized knowledge, and the expertise in order to be useful. Therefore, it is important to have a reliable and experienced partner to help you with your investigations.

Advantages of outsourcing foreign matter analysis include:

  • Access to a wide range of analytical techniques and instruments: Foreign matter analysis requires specialized equipment that is not found in every laboratory. Often, contamination occurs in trace amounts (such as a single particle), which requires specialized handling and microscopic analysis techniques.
  • Access to experience and expertise: Acquiring data from the instruments is one part of the analysis; using extensive databases, expertise, and prior experience to make sense of the results is another. 
  • Unpredictability of occurrence: Foreign matter contamination can occur at anytime, anywhere. Therefore, dedicating and maintaining instrumentation and full-time expertise specifically for this type of analysis can be costly and resource-inefficient.
Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.